0 followers
Check out our latest paper where we evaluate biomarkers from a clinical and economical point of view https://t.co/QLWkk1VVFb #SPVT22
Check out our latest paper where we evaluate biomarkers from a clinical and economical point of view https://t.co/QLWkk1VVFb #SPVT22
RT @FrontPharmacol: New Research: Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors https://t.co/9lb…
RT @FrontPharmacol: New Research: Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors https://t.co/9lb…
New Research: Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors https://t.co/9lbv6a9ifZ #pharmacology